Bioinformatics Market Synopsis
Bioinformatics Market size is expected to grow from USD 20.59 Billion in 2023 to USD 56.73 Billion by 2032, at a CAGR of 11.92% during the forecast period.
The use of biomolecules such as genomics, proteomics, and personalized medicine is continuing to drive fast growth in the bioinformatics market. It also involves use of soft wares and services that employ computational approaches in analyzing biological information that enhances research and development in fields such as the agricultural biotechnology, diagnostics and therapeutics. The trend on enhanced data analysis for life science applications, a rising use of high throughput technologies and a need for more targeted healthcare solutions fuels the growth of this market. As advancements in artificial intelligence and machine learning enhance data processing and analysis we expect bioinformatics industry to maintain growth path which would be beneficial for both incumbents and new players.
- The need for high quality analysis of data in biological and clinical fields is driving the bioinformatics market, a very promising subfield within the larger and diverse life sciences market. This market therefore consists of technologies and services necessary to approach, analyze and interpret highly complicated biological information such as genomics, proteomics, and metabolomics. High throughput technologies such as next-generation sequencing (NGS) and personalized medicine have generated a large amount of data and thereby led to a growing need for bioinformatics.
- Bio informatics is growing largely because of technological enhancements and because chronic diseases are becoming more recurrent and extensive application of bioinformatics in drug development. Technological improvements in artificial intelligence and advanced learning increase the power of bioinformatics in determining diseases and in finding possible therapeutic interventions. In addition, the global government as well as private budgets are allocating more money to research and development, enhancing market growth.
Bioinformatics Market Trend Analysis
Integration of AI and Machine Learning
- AI/ML based approaches are already making a sigificant impact in the bioinformatics market as they enhanced the ability to analyse and interpret data. Now such algorithms allow the scientists to process big amounts of biological data much faster and more accurately than it was done by hand, for example, sequences of genes or structures of proteins.
- With that said, this paper further expects that with advanced growth of these technologies, the incorporation into bioinformatics platforms will create future possibilities and innovation in the form of enhanced tools and applications which may include real time disease detection and superior models for prediction. This is typical for overall tendencies of using data-driven approaches in healthcare and highlights the further roles of AI and ML in bioinformatics progress.
Growth in Genomic Data Analysis
- The genomic data analysis and bioinformatics market has experienced solid growth pertaining to the growing research investment in genomic and distinct improvement in genomic technology. It is due to the ever increasing focus on the personalized medicine and precision health, as those working in the field try to find ways to apply the patients’ genetic profile towards prognosis and therapeutic management of diseases.
- Moreover, the use of AI and ML in bioinformatics is changing data analysis positively, and this trend is sure to continue. The algorithms developed by using capaAI optimize the capability of detecting and analyzing likely relationships between large volumes of genomic data results in faster advancement in diagnoses and treatments of genetic diseases.
Bioinformatics Market Segment Analysis:
Bioinformatics Market is segmented on the basis of Products and Services, and Application
By Products and Services, Knowledge Management Tools segment is expected to dominate the market during the forecast period
- The bioinformatics market is a quickly expanding segment, propelled by innovations involving the knowledge management tools, bioinformatics platforms and corresponding services. KM tools have a very important beneficial function forte in aggression, analysis and storage of enormous volumes of biological information. These tools enhance the ease of handling data and effects in the field of research and development in bioinformatics.
- Services included in the bioinformatics market also play a large role in contributing to the growth of the market. Some of these services are data analysis; software development; consulting services this help organizations to harness bioinformatics tools and platforms well. The exponentially rising trend of personalized medicine and genomics is projected to further create demand for bioinformatics market with more investments made towards technologies and services for data management, analytics and application.
By Application, Chemoinformatics & Drug Design segment held the largest share in 2024
- The bioinformatics market is growing across different applications due to the improvements of technology and attention to personalized medicine. These areas of interest are genomics, Chemoinformatic and drug design, proteomics, transcriptomics, and metabolomics.
- Transcriptomics looks at total cellular RNA and thus can identify gene expression options. Omics measures physiological or metabolic processes in an organism to determine changes in the presence of diseases. Altogether these applications provide comprehensible understanding about biological systems and that fosters advancements in drug discovery, disease studies, and treatment.
Bioinformatics Market Regional Insights:
North America is the largest region in the market
- North America holds the highest market share in the bioinformatics market since it has established research, better health care facilities and has a good number of biotechnological investments. Several companies, universities, and governmental programs are involved in supporting the bioinformatics growth in the United States and Canada, which act as leaders. This is alongside having the most investment in the use of innovative technologies, as well as having an advanced network already in place for data analysis and management.
- Currently, it is identified that it is modernizing rapidly in North America main concerns are personalized medication and genomic which has brought significant advancement of drugs and discovery in North America market. This is due to rapid technopolis adoption rate and the availability of leading pharmaceutical firms in the area. In addition, the North American bioinformatics industry enjoys constant expansion and evolution due to the action of market players along with research organizations that drive innovation.
Active Key Players in the Bioinformatics Market
- Illumina Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- Qiagen N.V. (Netherlands)
- Agilent Technologies Inc. (US)
- BGI Group (China)
- PerkinElmer Inc. (US)
- Eurofins Scientific SE (Europe)
- Waters Corporation (US)
- DNAnexus Inc. (US)
- Sophia Genetics SA (Switzerland)
- Partek Incorporated (US)
- Gene Codes Corporation (US)
- Dassault Systemes SE (France)
- Biomax Informatics AG (Germany)
- Bruker Corporation (US)
- GenoLogics Life Sciences Software Inc. (US)
- Nonlinear Dynamics Ltd. (Waters Corporation) (UK)
- Genedata AG (Switzerland)
- Knome Inc. (US)
- Macrogen Inc. (South Korea)
- others
Global Bioinformatics Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 20.59 Bn. |
Forecast Period 2024-32 CAGR: |
11.92% |
Market Size in 2032: |
USD 56.73 Bn. |
Segments Covered: |
By Products And Services |
|
|
By Application |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Technology & Services
3.2 By Application
3.3 By Sectors
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Bioinformatics Market by Technology & Services
5.1 Bioinformatics Market Overview Snapshot and Growth Engine
5.2 Bioinformatics Market Overview
5.3 Knowledge Management Tools
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Knowledge Management Tools: Geographic Segmentation
5.4 Bioinformatics Platforms
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Bioinformatics Platforms: Geographic Segmentation
5.5 Bioinformatics Services
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Bioinformatics Services: Geographic Segmentation
Chapter 6: Bioinformatics Market by Application
6.1 Bioinformatics Market Overview Snapshot and Growth Engine
6.2 Bioinformatics Market Overview
6.3 Metabolomics
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Metabolomics: Geographic Segmentation
6.4 Molecular Phylogenetics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Molecular Phylogenetics: Geographic Segmentation
6.5 Transcriptomics
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Transcriptomics: Geographic Segmentation
6.6 Proteomics
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Proteomics: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Bioinformatics Market by Sectors
7.1 Bioinformatics Market Overview Snapshot and Growth Engine
7.2 Bioinformatics Market Overview
7.3 Medical Bioinformatics
7.3.1 Introduction and Market Overview
7.3.2 Historic and Forecasted Market Size (2017-2032F)
7.3.3 Key Market Trends, Growth Factors and Opportunities
7.3.4 Medical Bioinformatics: Geographic Segmentation
7.4 Animal Bioinformatics
7.4.1 Introduction and Market Overview
7.4.2 Historic and Forecasted Market Size (2017-2032F)
7.4.3 Key Market Trends, Growth Factors and Opportunities
7.4.4 Animal Bioinformatics: Geographic Segmentation
7.5 Agriculture Bioinformatics
7.5.1 Introduction and Market Overview
7.5.2 Historic and Forecasted Market Size (2017-2032F)
7.5.3 Key Market Trends, Growth Factors and Opportunities
7.5.4 Agriculture Bioinformatics: Geographic Segmentation
7.6 Academics
7.6.1 Introduction and Market Overview
7.6.2 Historic and Forecasted Market Size (2017-2032F)
7.6.3 Key Market Trends, Growth Factors and Opportunities
7.6.4 Academics: Geographic Segmentation
7.7 Others
7.7.1 Introduction and Market Overview
7.7.2 Historic and Forecasted Market Size (2017-2032F)
7.7.3 Key Market Trends, Growth Factors and Opportunities
7.7.4 Others: Geographic Segmentation
Chapter 8: Company Profiles and Competitive Analysis
8.1 Competitive Landscape
8.1.1 Competitive Positioning
8.1.2 Bioinformatics Sales and Market Share By Players
8.1.3 Industry BCG Matrix
8.1.4 Heat Map Analysis
8.1.5 Bioinformatics Industry Concentration Ratio (CR5 and HHI)
8.1.6 Top 5 Bioinformatics Players Market Share
8.1.7 Mergers and Acquisitions
8.1.8 Business Strategies By Top Players
8.2 AGILENT TECHNOLOGIES INC. (UNITED STATES)
8.2.1 Company Overview
8.2.2 Key Executives
8.2.3 Company Snapshot
8.2.4 Operating Business Segments
8.2.5 Product Portfolio
8.2.6 Business Performance
8.2.7 Key Strategic Moves and Recent Developments
8.2.8 SWOT Analysis
8.3 BIOMAX INFORMATICS AG (GERMANY)
8.4 HYBRIGENICS (FRANCE)
8.5 LUMENOGIX (INDIA)
8.6 DNANEXUS INC. (UNITED STATES)
8.7 GENEDATA AG (SWITZERLAND)
8.8 INTREXON BIOINFORMATICS GERMANY GMBH (GERMANY)
8.9 ILLUMINA INC. (UNITED STATES)
8.10 PERKINELMER INC. (UNITED STATES)
8.11 QIAGEN N.V. (GERMANY)
8.12 SEVEN BRIDGES GENOMICS INC. (UNITED STATES)
8.13 THERMO FISHER SCIENTIFIC INC. (UNITED STATES)
8.14 OTHER MAJOR PLAYERS
Chapter 9: Global Bioinformatics Market Analysis, Insights and Forecast, 2017-2032
9.1 Market Overview
9.2 Historic and Forecasted Market Size By Technology & Services
9.2.1 Knowledge Management Tools
9.2.2 Bioinformatics Platforms
9.2.3 Bioinformatics Services
9.3 Historic and Forecasted Market Size By Application
9.3.1 Metabolomics
9.3.2 Molecular Phylogenetics
9.3.3 Transcriptomics
9.3.4 Proteomics
9.3.5 Others
9.4 Historic and Forecasted Market Size By Sectors
9.4.1 Medical Bioinformatics
9.4.2 Animal Bioinformatics
9.4.3 Agriculture Bioinformatics
9.4.4 Academics
9.4.5 Others
Chapter 10: North America Bioinformatics Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Technology & Services
10.4.1 Knowledge Management Tools
10.4.2 Bioinformatics Platforms
10.4.3 Bioinformatics Services
10.5 Historic and Forecasted Market Size By Application
10.5.1 Metabolomics
10.5.2 Molecular Phylogenetics
10.5.3 Transcriptomics
10.5.4 Proteomics
10.5.5 Others
10.6 Historic and Forecasted Market Size By Sectors
10.6.1 Medical Bioinformatics
10.6.2 Animal Bioinformatics
10.6.3 Agriculture Bioinformatics
10.6.4 Academics
10.6.5 Others
10.7 Historic and Forecast Market Size by Country
10.7.1 U.S.
10.7.2 Canada
10.7.3 Mexico
Chapter 11: Europe Bioinformatics Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Technology & Services
11.4.1 Knowledge Management Tools
11.4.2 Bioinformatics Platforms
11.4.3 Bioinformatics Services
11.5 Historic and Forecasted Market Size By Application
11.5.1 Metabolomics
11.5.2 Molecular Phylogenetics
11.5.3 Transcriptomics
11.5.4 Proteomics
11.5.5 Others
11.6 Historic and Forecasted Market Size By Sectors
11.6.1 Medical Bioinformatics
11.6.2 Animal Bioinformatics
11.6.3 Agriculture Bioinformatics
11.6.4 Academics
11.6.5 Others
11.7 Historic and Forecast Market Size by Country
11.7.1 Germany
11.7.2 U.K.
11.7.3 France
11.7.4 Italy
11.7.5 Russia
11.7.6 Spain
11.7.7 Rest of Europe
Chapter 12: Asia-Pacific Bioinformatics Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Technology & Services
12.4.1 Knowledge Management Tools
12.4.2 Bioinformatics Platforms
12.4.3 Bioinformatics Services
12.5 Historic and Forecasted Market Size By Application
12.5.1 Metabolomics
12.5.2 Molecular Phylogenetics
12.5.3 Transcriptomics
12.5.4 Proteomics
12.5.5 Others
12.6 Historic and Forecasted Market Size By Sectors
12.6.1 Medical Bioinformatics
12.6.2 Animal Bioinformatics
12.6.3 Agriculture Bioinformatics
12.6.4 Academics
12.6.5 Others
12.7 Historic and Forecast Market Size by Country
12.7.1 China
12.7.2 India
12.7.3 Japan
12.7.4 Singapore
12.7.5 Australia
12.7.6 New Zealand
12.7.7 Rest of APAC
Chapter 13: Middle East & Africa Bioinformatics Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Technology & Services
13.4.1 Knowledge Management Tools
13.4.2 Bioinformatics Platforms
13.4.3 Bioinformatics Services
13.5 Historic and Forecasted Market Size By Application
13.5.1 Metabolomics
13.5.2 Molecular Phylogenetics
13.5.3 Transcriptomics
13.5.4 Proteomics
13.5.5 Others
13.6 Historic and Forecasted Market Size By Sectors
13.6.1 Medical Bioinformatics
13.6.2 Animal Bioinformatics
13.6.3 Agriculture Bioinformatics
13.6.4 Academics
13.6.5 Others
13.7 Historic and Forecast Market Size by Country
13.7.1 Turkey
13.7.2 Saudi Arabia
13.7.3 Iran
13.7.4 UAE
13.7.5 Africa
13.7.6 Rest of MEA
Chapter 14: South America Bioinformatics Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Technology & Services
14.4.1 Knowledge Management Tools
14.4.2 Bioinformatics Platforms
14.4.3 Bioinformatics Services
14.5 Historic and Forecasted Market Size By Application
14.5.1 Metabolomics
14.5.2 Molecular Phylogenetics
14.5.3 Transcriptomics
14.5.4 Proteomics
14.5.5 Others
14.6 Historic and Forecasted Market Size By Sectors
14.6.1 Medical Bioinformatics
14.6.2 Animal Bioinformatics
14.6.3 Agriculture Bioinformatics
14.6.4 Academics
14.6.5 Others
14.7 Historic and Forecast Market Size by Country
14.7.1 Brazil
14.7.2 Argentina
14.7.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Global Bioinformatics Market |
|||
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 20.59 Bn. |
Forecast Period 2024-32 CAGR: |
11.92% |
Market Size in 2032: |
USD 56.73 Bn. |
Segments Covered: |
By Products And Services |
|
|
By Application |
|
||
By Region |
|
||
Key Market Drivers: |
|
||
Key Market Restraints: |
|
||
Key Opportunities: |
|
||
Companies Covered in the report: |
|
Frequently Asked Questions :
The forecast period in the Bioinformatics Market research report is 2024-2032.
Illumina Inc. (US), Thermo Fisher Scientific Inc. (US), Qiagen N.V. (Netherlands), Agilent Technologies Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Eurofins Scientific SE (Europe), Waters Corporation (US), DNAnexus Inc. (US), Sophia Genetics SA (Switzerland), Partek Incorporated (US), Gene Codes Corporation (US), Dassault Systemes SE (France), Biomax Informatics AG (Germany), Bruker Corporation (US), GenoLogics Life Sciences Software Inc. (US), Nonlinear Dynamics Ltd. (Waters Corporation) (UK), Genedata AG (Switzerland), Knome Inc. (US), Macrogen Inc. (South Korea), others.
The Bioinformatics Market is segmented into By Products And Services(Knowledge Management Tools, Bioinformatics Platform, Services), Application(Genomics, Chemoinformatics & Drug Design, Proteomics, Transcriptomics, Metabolomics, Other). By region, it is analyzed across North America (U.S.; Canada; Mexico), Eastern Europe (Bulgaria; The Czech Republic; Hungary; Poland; Romania; Rest of Eastern Europe), Western Europe (Germany; UK; France; Netherlands; Italy; Russia; Spain; Rest of Western Europe), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).
Bioinformatics is a multidisciplinary field that combines biology, computer science, and mathematics to analyze and interpret complex biological data. It plays a crucial role in various areas such as genomics, proteomics, and drug discovery by leveraging computational tools and algorithms to manage, process, and understand vast amounts of biological information. This field facilitates advancements in personalized medicine, helps in identifying genetic variations linked to diseases, and accelerates the development of targeted therapies, making it essential for modern biological research and clinical applications.
Bioinformatics Market size is expected to grow from USD 20.59 Billion in 2023 to USD 56.73 Billion by 2032, at a CAGR of 11.92% during the forecast period.